AURO LABORATORIES LTD. Share Price

Auro Laboratories Limited is an India-based company, which is engaged in the manufacturing activities of active pharmaceutical ingredients (APIs). The Company is specializing in producing anti-diabetics like Metformin HCL, which is used in the treatment of type 2 diabetes. It also undertakes toll/custom manufacturing for API's and intermediates on a contract basis. The Company's API products include antihistamine, muscle relaxant, diuretic, iron deficiency, anti-diabetics, anti-fungal, anti-ulcer, iodine supplement, anti-malaria, analgesics, antacids, anti-inflammatory, specialty chemicals and others. Its intermediate products include glibenclamde sulphonamide, cis-bramo benzoate, cls-tosylate, 2-ethoxy benzoic acid, 2-ethoxy benzoic acid, among others. It offers its manufacturing and technical services, such as process scale up, process optimization, custom synthesis and custom manufacturing. It exports to Southeast Asia, Middle East and several European countries.As of 25 May 2026, AURO LABORATORIES LTD. share price is ₹270.85. The stock opened at ₹263.15, compared to its previous close of ₹269.90. During today's trading session, AURO LABORATORIES LTD. share price moved in the range of ₹263.15 to ₹278.70, with an average price of ₹270.92 for the day. Looking at its last 52-week, the stock has touched a low of ₹263.15 and a high of ₹278.70.

The market capitalization of AURO LABORATORIES LTD. is ₹168 Crs, with a P/E ratio of 91.5 and a dividend yield of 0.00%.